Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)

  1. Powles, T.
  2. Kockx, M.
  3. Rodriguez-Vida, A.
  4. Duran, I.
  5. Crabb, S.J.
  6. Van Der Heijden, M.S.
  7. Szabados, B.
  8. Pous, A.F.
  9. Gravis, G.
  10. Herranz, U.A.
  11. Protheroe, A.
  12. Ravaud, A.
  13. Maillet, D.
  14. Mendez, M.J.
  15. Suarez, C.
  16. Linch, M.
  17. Prendergast, A.
  18. van Dam, P.-J.
  19. Stanoeva, D.
  20. Daelemans, S.
  21. Mariathasan, S.
  22. Tea, J.S.
  23. Mousa, K.
  24. Banchereau, R.
  25. Castellano, D.
Aldizkaria:
Nature Medicine

ISSN: 1546-170X,  1078-8956

Argitalpen urtea: 2023

Mota: Hutsen zuzenketa

DOI: 10.1038/S41591-023-02312-9 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus